FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← DYN · Dyne Therapeutics, Inc.
424B5The Raise

Dyne Therapeutics, Inc. files 424B5

Filed Jan 3, 2024 · 2y ago · Accession 0001193125-24-001541

Plain English

424B5 filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Dyne Therapeutics, Inc.
Ticker
DYN
CIK
1818794
Form type
424B5
Filing date
Jan 3, 2024
Report date
—
Document
d679330d424b5.htm
Size
525 KB

More from DYN

8-KExecutive ChangeJun 22, 20268-KMaterial Agreement · New Debt / ObligationJun 17, 20268-KShareholder VoteJun 8, 20268-KReg FD Disclosure · Company UpdateJun 3, 202610-QThe RecordMay 11, 20268-KResults of OperationsMay 11, 2026